Impax Laboratories (IPXL) and GlaxoSmithKline (GSK) announce positive top-line results of a...

|About: Impax Laboratories, Inc. (IPXL)|By:, SA News Editor

Impax Laboratories (IPXL) and GlaxoSmithKline (GSK) announce positive top-line results of a Parkinson's disease study, as the firms move forward with their applications to the FDA and European Union. Premarket: IPXL +8.9%, GSK +0.8%. (PR)